Olufunmilayo Olopade
#16,966
Most Influential Person Now
Nigerian physician
Olufunmilayo Olopade's AcademicInfluence.com Rankings
Olufunmilayo Olopademedical Degrees
Medical
#355
World Rank
#505
Historical Rank
Public Health
#121
World Rank
#128
Historical Rank
Epidemiology
#279
World Rank
#296
Historical Rank
Olufunmilayo Olopadebiology Degrees
Biology
#3301
World Rank
#5065
Historical Rank
Genetics
#470
World Rank
#541
Historical Rank
Download Badge
Medical Biology
Olufunmilayo Olopade's Degrees
- Masters Medicine University of Ibadan
- Masters Public Health University of Illinois Chicago
- Masters Epidemiology University of Ibadan
- PhD Human Genetics University of Ibadan
Why Is Olufunmilayo Olopade Influential?
(Suggest an Edit or Addition)According to Wikipedia, Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Olufunmilayo Olopade's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive molecular portraits of human breast tumors (2012) (7791)
- Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. (2002) (1469)
- The molecular portraits of breast tumors are conserved across microarray platforms (2006) (1436)
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer (2015) (1332)
- Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors (2007) (1247)
- Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma (2006) (1061)
- Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. (2010) (1008)
- Association analysis identifies 65 new breast cancer risk loci (2017) (922)
- Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (2004) (865)
- Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. (1999) (676)
- Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. (2004) (624)
- Salpingo-Oophorectomy and the Risk Of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation (2006) (566)
- Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer (2008) (490)
- Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. (2010) (461)
- Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations (2007) (458)
- Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. (2016) (422)
- Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (2005) (412)
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
- Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (2015) (390)
- Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (2002) (369)
- Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. (2009) (366)
- p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. (1994) (329)
- Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. (2006) (328)
- The Chromosomes in Human Cancer and Leukemia (1981) (325)
- Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. (2006) (322)
- Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) (2011) (318)
- Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. (2012) (317)
- MYC and Breast Cancer. (2010) (303)
- Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer (2004) (283)
- RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. (2007) (276)
- Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update (2006) (270)
- Targeting health disparities: a model linking upstream determinants to downstream interventions. (2008) (268)
- A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies (2006) (260)
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome (2011) (247)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- A Meta-Analysis Identifies New Loci Associated with Body Mass index in Individuals of African Ancestry (2013) (244)
- Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. (2005) (243)
- Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2008) (238)
- A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change (2015) (233)
- Assembly of a pan-genome from deep sequencing of 910 humans of African descent (2018) (229)
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 (2013) (226)
- Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (2011) (213)
- Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay (2006) (212)
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
- Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. (1997) (205)
- Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. (1992) (203)
- ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. (2012) (201)
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. (2019) (196)
- Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
- BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. (2005) (192)
- Treatment of cancer in sub-Saharan Africa. (2013) (189)
- Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression (2008) (184)
- Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers (2005) (183)
- Advances in Breast Cancer: Pathways to Personalized Medicine (2008) (182)
- The role of tumor-associated macrophages in breast cancer progression (2013) (181)
- A compact VEGF signature associated with distant metastases and poor outcomes (2009) (179)
- Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas (2017) (178)
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer (2014) (176)
- Breast cancer genetics in African Americans (2003) (171)
- Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. (1993) (169)
- X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis (2007) (169)
- Disparities in genetic testing: thinking outside the BRCA box. (2006) (157)
- Rapid progression of prostate cancer in men with a BRCA2 mutation (2008) (156)
- Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer: Promising Clinical Target or Only a Marker? (2010) (156)
- Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma (2011) (156)
- The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. (2005) (151)
- Colorectal cancer model of health disparities: understanding mortality differences in minority populations. (2006) (150)
- An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. (2008) (150)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
- Structure of the human type-I interferon gene cluster determined from a YAC clone contig. (1994) (147)
- Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. (1998) (145)
- Cyclin D1 Amplification and p16(MTS1/CDK4I) Deletion Correlate With Poor Prognosis in Head and Neck Tumors (2002) (144)
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores (2017) (142)
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells (2015) (141)
- Male breast cancer in Cowden syndrome patients with germlinePTEN mutations (2001) (136)
- Effect of BRCA germline mutations on breast cancer prognosis (2016) (136)
- MYC in breast tumor progression (2008) (132)
- Increased p16 levels correlate with pRb alterations in human urothelial cells. (1995) (128)
- Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. (2002) (127)
- Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo‐astrocytomas (1992) (125)
- Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study (2013) (124)
- Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemia (2016) (123)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome (2016) (120)
- Early onset HER2‐positive breast cancer is associated with germline TP53 mutations (2012) (116)
- Transforming Epidemiology for 21st Century Medicine and Public Health (2013) (116)
- Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11) (1990) (116)
- Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer (2013) (114)
- Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location. (2004) (114)
- Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival (2011) (114)
- Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus (2010) (113)
- DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (112)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling. (2013) (109)
- Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. (1992) (108)
- An update on the management of breast cancer in Africa (2017) (106)
- Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. (2015) (104)
- Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms (2004) (103)
- BRCA2 T2722R is a deleterious allele that causes exon skipping. (2002) (102)
- Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. (2002) (102)
- Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
- HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways (2018) (100)
- MYC Is Amplified in BRCA1-Associated Breast Cancers (2004) (99)
- EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer (2003) (97)
- Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers (2007) (96)
- Inherited predisposition to breast cancer among African American women (2014) (96)
- Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment. (2007) (95)
- Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. (1992) (95)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. (2002) (95)
- Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. (1994) (94)
- Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study (2018) (93)
- Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2005) (93)
- A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria (2018) (91)
- Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. (2005) (91)
- Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers (2010) (90)
- MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion (2012) (89)
- The Breast–Thyroid Cancer Link: A Systematic Review and Meta-analysis (2016) (87)
- Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. (1995) (86)
- Computerized Texture Analysis of Mammographic Parenchymal Patterns of Digitized Mammograms1 (2005) (86)
- How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. (2007) (85)
- Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers (2008) (85)
- RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma (2011) (85)
- Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. (2020) (85)
- Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers (2011) (85)
- Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes (2013) (84)
- Mammary Cancer and Social Interactions: Identifying Multiple Environments That Regulate Gene Expression Throughout the Life Span. (2005) (84)
- Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 (2016) (84)
- The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer (2015) (82)
- Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population (2015) (81)
- Confronting genetic testing disparities: knowledge is power. (2005) (81)
- Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
- REPORT on the Third International Workshop on Chromosome 9 (1994) (79)
- Abstract S5-02: Veliparib/carboplatin plus standard neoadjuvant therapy for high-risk breast cancer: First efficacy results from the I-SPY 2 TRIAL (2013) (78)
- High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients (2012) (78)
- The impact of site-specific digital histology signatures on deep learning model accuracy and bias (2021) (77)
- Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. (2010) (76)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers (2004) (76)
- UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of Women (2007) (75)
- Tumor genome analysis includes germline genome: Are we ready for surprises? (2014) (75)
- “Why take it if you don’t have anything?” breast cancer risk perceptions and prevention choices at a public hospital (2006) (75)
- A genome-wide association study of breast cancer in women of African ancestry (2012) (74)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
- Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts (2007) (73)
- Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density. (2013) (73)
- FANCF methylation contributes to chemoselectivity in ovarian cancer. (2003) (73)
- Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. (2012) (72)
- Identification of a circulating MicroRNA signature to distinguish recurrence in breast cancer patients (2016) (71)
- Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer (2019) (71)
- Inherited Breast Cancer in Nigerian Women (2018) (70)
- Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility (2014) (70)
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
- Racial differences in genetic factors associated with breast cancer (2003) (69)
- Building capacity for sustainable research programmes for cancer in Africa (2014) (68)
- Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer (2007) (68)
- Efficacy of Risk‐Reducing Salpingo‐Oophorectomy in Women with BRCA‐1 and BRCA‐2 Mutations (2004) (67)
- The Importance of Transdisciplinary Collaborations for Understanding and Resolving Health Disparities (2010) (67)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer (2001) (67)
- Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. (1994) (67)
- Genetic susceptibility to breast cancer (2007) (65)
- Social barriers to diagnosis and treatment of breast cancer in patients presenting at a teaching hospital in Ibadan, Nigeria (2015) (64)
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers (2010) (63)
- Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution (2011) (63)
- Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. (1996) (63)
- Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. (1995) (62)
- Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry (2016) (62)
- DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial (2017) (61)
- Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features (2018) (61)
- The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation (2013) (61)
- National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. (2014) (61)
- Codeletion of CDKN2 and MTAP genes in a subset of non‐Hodgkin's lymphoma may be associated with histologic transformation from low‐grade to diffuse large‐cell lymphoma (1998) (60)
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
- Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. (1993) (59)
- Obesity and height in urban Nigerian women with breast cancer. (2003) (59)
- Phase II trial of temsirolimus in patients with metastatic breast cancer (2012) (58)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers (2014) (58)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (58)
- Proceedings from the 9th annual conference on the science of dissemination and implementation (2017) (57)
- Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. (2011) (57)
- Epidemiology of Triple-Negative Breast Cancer: A Review. (2021) (55)
- Direct-to-consumer marketing of genetic tests for cancer: buyer beware. (2003) (55)
- Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations (2019) (55)
- Power Spectral Analysis of Mammographic Parenchymal Patterns for Breast Cancer Risk Assessment (2008) (55)
- Genetic Determinants of Breast Cancer Risk: A Review of Current Literature and Issues Pertaining to Clinical Application (2012) (55)
- Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. (2001) (55)
- Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers (2006) (54)
- Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. (2016) (54)
- RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. (2008) (54)
- When parents disclose BRCA1/2 test results: Their communication and perceptions of offspring response (2012) (54)
- Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers (2009) (53)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer (2013) (53)
- Male breast cancer in Cowden syndrome patients with germline PTEN mutations (2001) (52)
- Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. (1995) (52)
- Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis (2013) (51)
- Case-control study of body size and breast cancer risk in Nigerian women. (2010) (50)
- Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer (2000) (49)
- Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer (2010) (49)
- Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study (2012) (48)
- DNA repair genes XPC, XPG polymorphisms: Relation to the risk of colorectal carcinoma and therapeutic outcome with oxaliplatin‐based adjuvant chemotherapy (2012) (48)
- Learning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences (2009) (47)
- Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy (2016) (47)
- Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. (2009) (47)
- Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry (2012) (47)
- Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis. (1997) (47)
- Oral Contraceptives and the Risk of Breast Cancer in BRCA 1 and BRCA 2 Mutation Carriers (2002) (47)
- Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: β2‐glycoprotein I antibodies as a marker of response to therapy (1999) (46)
- A Comparison of Bilateral Breast Cancers in BRCA Carriers (2005) (46)
- Effect of stove intervention on household air pollution and the respiratory health of women and children in rural Nigeria (2013) (46)
- Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling (2019) (45)
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. (2018) (45)
- Relationship between Household Air Pollution from Biomass Smoke Exposure, and Pulmonary Dysfunction, Oxidant-Antioxidant Imbalance and Systemic Inflammation in Rural Women and Children in Nigeria (2013) (44)
- Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples (2016) (44)
- CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors (2010) (44)
- Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. (2015) (44)
- β‐catenin regulates c‐Myc and CDKN1A expression in breast cancer cells (2016) (44)
- Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. (2001) (42)
- Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. (2012) (42)
- Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition (2013) (41)
- Novel germline PALB2 truncating mutations in African American breast cancer patients (2012) (40)
- Concordance in histological and biological parameters between first and second primary breast cancers (2011) (40)
- c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells (2011) (40)
- Computerized Analysis of Mammographic Parenchymal Patterns on a Large Clinical Dataset of Full-Field Digital Mammograms: Robustness Study with Two High-Risk Datasets (2012) (40)
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). (2020) (40)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (39)
- Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis (2019) (39)
- Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. (2009) (39)
- Alcohol Consumption and Breast Cancer Risk among Women in Three Sub-Saharan African Countries (2014) (39)
- Expression of Polycomb Targets Predicts Breast Cancer Prognosis (2013) (39)
- Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences (2018) (38)
- Breast Cancer and Race: A Rising Tide Does Not Lift All Boats Equally (2005) (38)
- Genetic Testing in an Ethnically Diverse Cohort of High-Risk Women: A Comparative Analysis of BRCA1 and BRCA2 Mutations in American families of European and African Ancestry (2006) (38)
- Level of awareness of mammography among women attending outpatient clinics in a teaching hospital in Ibadan, South-West Nigeria (2013) (38)
- AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study (2007) (37)
- Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (2014) (37)
- Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring (2008) (37)
- Glucocorticoid receptor expression in breast cancer associates with older patient age (2009) (37)
- The 9p21 region in bladder cancer cell lines: large homozygous deletions inactivate the CDKN2, CDKN2B and MTAP genes (2004) (36)
- Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study (2014) (36)
- A functionally significant SNP in TP53 and breast cancer risk in African-American women (2017) (36)
- Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models. (2014) (36)
- Early-life conditions and mechanisms of population health vulnerabilities. (2007) (35)
- Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry (2018) (35)
- Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays. (2008) (34)
- Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. (2012) (34)
- A comprehensive examination of breast cancer risk loci in African American women. (2014) (34)
- Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines (1994) (34)
- Evidence of a founder BRCA1 mutation in Scotland (2000) (33)
- Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. (2019) (33)
- Racial and ethnic disparities in breast cancer: a multilevel perspective. (2005) (33)
- Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers (2018) (33)
- Cancer genetics in oncology practice. (2001) (33)
- Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? (2013) (33)
- Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans (2008) (33)
- Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013 (2016) (33)
- Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation (2016) (32)
- Translational integrity and continuity: Personalized biomedical data integration (2009) (32)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
- Allelic imbalance (AI) identifies novel tissue‐specific cis‐regulatory variation for human UGT2B15 (2010) (32)
- Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study (2014) (31)
- Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome (2017) (31)
- Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study (2020) (31)
- Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer. (2019) (31)
- CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine. (2011) (31)
- A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk (2011) (30)
- Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results (2018) (30)
- Three Tests for Measuring Unjustified Disparate Impacts in Organ Transplantation: The Problem of "Included Variable" Bias (2005) (30)
- Translational Cancer Research (2009) (30)
- Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (29)
- Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial) (2012) (29)
- Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry (2016) (28)
- Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. (2013) (28)
- Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas (2019) (28)
- Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population (2010) (27)
- Clinical significance of KISS1 protein expression for brain invasion and metastasis (2012) (27)
- Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent (2008) (27)
- Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study. (2013) (27)
- Familial myeloid leukemia associated with loss of the long arm of chromosome 5. (1996) (27)
- Cancer Survivorship Care: Exploring the Role of the General Internist (2009) (27)
- Scaffold-associated regions in the human type I interferon gene cluster on the short arm of chromosome 9. (1998) (27)
- Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry (2008) (27)
- The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study (2016) (26)
- Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis (2018) (26)
- LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications (2018) (26)
- Performance of Lynch Syndrome Predictive Models in a Multi-Center US Referral Population (2011) (26)
- MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency (2013) (26)
- Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases. (2013) (25)
- Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2018) (25)
- Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer (2016) (25)
- The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries (2019) (25)
- Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology. (2016) (25)
- An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
- Race, ethnicity, and the diagnosis of breast cancer. (2015) (24)
- Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy? (2018) (24)
- Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States (2017) (24)
- Fourier components of inhomogeneously broadened water resonances in breast: A new source of MRI contrast (2004) (24)
- Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers. (2014) (23)
- Parent opinions regarding the genetic testing of minors for BRCA1/2. (2010) (23)
- Mutations in context: implications of BRCA testing in diverse populations (2018) (22)
- A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
- The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. (2006) (22)
- Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials (2013) (22)
- rs2981582 is associated with FGFR2 expression in normal breast. (2010) (22)
- The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast (2003) (22)
- Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter (2015) (22)
- Pilot Survey of Breast Cancer Management in Sub-Saharan Africa (2016) (22)
- BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry (2019) (22)
- Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. (2021) (22)
- Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group. (2018) (22)
- "Intrinsic Gene Expression" subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestry. (2004) (21)
- Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity (2013) (21)
- Household air pollution and chronic hypoxia in the placenta of pregnant Nigerian women: A randomized controlled ethanol Cookstove intervention. (2018) (21)
- Neo-adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource-poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study (2013) (21)
- Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer (2013) (21)
- Population-dependent Intron Retention and DNA Methylation in Breast Cancer (2018) (21)
- Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine. (1996) (21)
- Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: Qualitative and quantitative comparisons (2006) (21)
- The Expanding Use of Third-Generation Aromatase Inhibitors: What the General Internist Needs to Know (2009) (20)
- Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon (2019) (20)
- Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo (2015) (20)
- Disparities in cancer care: a worldwide perspective and roadmap for change. (2006) (20)
- Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 (2016) (20)
- CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations (2018) (20)
- High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. (2006) (20)
- CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B‐ and T‐cell origin but is frequent in acute lymphoblastic leukaemia (1995) (20)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers. (2015) (19)
- Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (2011) (19)
- Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression. (2000) (19)
- Evaluation of BRCA1 inactivation by promoter methylation as a marker of triple-negative and basal-like breast cancers. (2010) (19)
- Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q (2000) (19)
- Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (2019) (19)
- Genetic testing in diverse populations: are researchers doing enough to get out the correct message? (2007) (19)
- Risk assessment and genetic testing for ovarian cancer. (2010) (18)
- Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3'UTR. (2011) (18)
- Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry (2017) (18)
- Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers (2011) (18)
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
- The Impact of Digital Histopathology Batch Effect on Deep Learning Model Accuracy and Bias (2020) (17)
- Preferences for in‐person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study (2018) (17)
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
- Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk (2018) (17)
- Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention (2017) (17)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- Molecular subtypes of breast cancer (2014) (16)
- Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers (2011) (16)
- Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage. (2010) (16)
- Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients (2021) (16)
- Mapping a putative tumor suppressor gene on chromosome 9 bands p21-p22 with microdissection probes. (1994) (16)
- Echo‐planar spectroscopic imaging (EPSI) of the water resonance structure in human breast using sensitivity encoding (SENSE) (2010) (16)
- The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort (2021) (16)
- Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry (2012) (16)
- Incoming resident interest in global health: occasional travel versus a future career abroad? (2011) (16)
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response (2019) (16)
- Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
- Fourier component imaging of water resonance in the human breast provides markers for malignancy (2009) (15)
- Race, the microbiome and colorectal cancer (2019) (15)
- MicroRNA-30 c targets cytoskeleton genes involved in breast cancer cell invasion (2012) (15)
- Mammographic breast pattern in Nigerian women in Ibadan, Nigeria. (2011) (15)
- Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma. (2013) (15)
- Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base. (2020) (15)
- Results from MAGENTA: A national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk. (2020) (15)
- A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
- Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. (2012) (15)
- The global role, impact, and limitations of Community Health Workers (CHWs) in breast cancer screening: a scoping review and recommendations to promote health equity for all (2021) (14)
- Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013 (2016) (14)
- Prevalence and Etiology of Bacteremia in Febrile Children with Sickle Cell Disease at a Nigeria Tertiary Hospital (2017) (14)
- Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions (2020) (14)
- Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. (2011) (14)
- Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. (2017) (14)
- Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. (2001) (14)
- Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect (2016) (13)
- Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer (2021) (13)
- Racial disparities in survival outcomes among breast cancer patients by molecular subtypes (2020) (13)
- Infrastructural Challenges Lead to Delay of Curative Radiotherapy in Nigeria (2020) (13)
- Development of a Breast Cancer Risk Prediction Model for Women in Nigeria (2018) (13)
- Mammary cancer and social interactions: identifying multiple environments that regulate gene expression throughout the life span. (2005) (12)
- A response to “Personalised medicine and population health: breast and ovarian cancer” (2019) (12)
- Relationships between Plasma Micronutrients, Serum IgE, and Skin Test Reactivity and Asthma among School Children in Rural Southwest Nigeria (2014) (12)
- Single-day FISH procedure for paraffin-embedded tissue sections using a microwave oven. (2005) (12)
- Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis (2019) (12)
- Implementation of a Novel Medical School Multidisciplinary and Interprofessional Oncology Curriculum: a Mixed Method Study (2019) (12)
- The academic health center in complex humanitarian emergencies: lessons learned from the 2010 Haiti earthquake. (2012) (12)
- Microsatellites in the Estrogen Receptor (ESR1, ESR2) and Androgen Receptor (AR) Genes and Breast Cancer Risk in African American and Nigerian Women (2012) (12)
- Hormone receptor negative and basal-like subtypes are overrepresented in invasive breast carcinoma from women of African ancestry (2005) (12)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
- Reducing Disparities in Breast Cancer Survival: A Columbia University and Avon Breast Cancer Research and Care Network Symposium* (2002) (11)
- Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer (2017) (11)
- Erratum: Early onset HER2‐positive breast cancer is associated with germline TP53 mutations (2012) (11)
- Breast cancer risk after full‐term pregnancies among African women from Nigeria, Cameroon, and Uganda (2015) (11)
- Genetics in clinical cancer care--the future is now. (1996) (11)
- SNP discovery, expression and cis-regulatory variation in the UGT2B genes (2011) (11)
- Causes and remedies for low research productivity among postgraduate scholars and early career researchers on non-communicable diseases in Nigeria (2019) (11)
- Incorporating a Psychological Counselor in a Cancer Risk Assessment Program: Necessity, Acceptability, and Potential Roles (2002) (11)
- Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization. (1997) (11)
- An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population (2017) (10)
- Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers (2019) (10)
- AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study (2007) (10)
- Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. (2021) (10)
- The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
- Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features (2019) (10)
- BRCA2 mutation and the risk of hematologic malignancy. (2006) (10)
- Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women (2021) (10)
- Genetic Susceptibility to Type 2 Diabetes and Breast Cancer Risk in Women of European and African Ancestry (2012) (10)
- Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria (2019) (9)
- Atopy Is Associated with Asthma in Adults Living in Rural and Urban Southwestern Nigeria (2011) (9)
- Traditional medicine usage among adult women in Ibadan, Nigeria: a cross-sectional study (2020) (9)
- Genetic variation in the vitamin D related pathway and breast cancer risk in women of African ancestry in the root consortium (2018) (9)
- 532 Evaluation of a BRCAness signature as a predictive biomarker of response to veliparib/carboplatin plus standard neoadjuvant therapy in high-risk breast cancer: results from the I-SPY 2 trial (2014) (9)
- Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers. (2018) (9)
- Ophira M. GinsburgCharmaine Kim-SingWilliam D. Foulkes • Parviz GhadirianHenry T. LynchPing SunSteven A. Narod • Hereditary Breast Cancer Clinical Study Group (2010) (9)
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
- Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2 (2016) (9)
- The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now. (2019) (9)
- Classification of breast lesions pre‐contrast injection using water resonance lineshape analysis (2013) (9)
- The WISDOM study: a new approach to screening can and should be tested (2021) (9)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2016) (9)
- Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study. (2018) (9)
- Fast bilateral breast coverage with high spectral and spatial resolution (HiSS) MRI at 3T (2017) (9)
- The American society of clinical oncology position on genetic testing (1997) (9)
- Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores (2021) (9)
- Family History of Pancreatic Cancer in a High-Risk Cancer Clinic: Implications for Risk Assessment (2008) (9)
- Establishment of a Standing Ethics/Institutional Review Board in a Nigerian University: A Blueprint for Developing Countries (2007) (9)
- The Human Genome Project and breast cancer. (1997) (8)
- Intestinal Helminthic Infection Increases Serum Levels of IL-2 and Decreases Serum TGF-Beta Levels in Nigerian Asthmatic Patients (2014) (8)
- Interpretation of genome-wide association study results. (2010) (8)
- Willingness to Participate in Health Information Networks with Diverse Data Use: Evaluating Public Perspectives (2019) (8)
- Genetic Testing for Susceptibility to Cancer (1998) (8)
- glycemic control and pain threshold in alloxan diabetic rats (2010) (8)
- LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women (2018) (8)
- A phase II trial of a mammalian target of rapamycin inhibitor, temsirolimus, in patients with metastatic breast cancer. (2009) (8)
- Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy? (2011) (8)
- Correlates of Depressive Symptoms Among Women Seeking Cancer Genetic Counseling and Risk Assessment at a High-Risk Cancer Clinic (2006) (7)
- Association of breast cancer risk and the mTOR pathway in women of African ancestry in ‘The Root’ Consortium (2017) (7)
- Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next-generation sequencing. (2013) (7)
- Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study (2019) (7)
- Breast Cancer Risk–Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel (2019) (7)
- GENETICS OF BREAST CANCER IN WOMEN OF AFRICAN DESCENT: AN OVERVIEW (2006) (7)
- Molecular profiles of breast cancer in Ilorin, Nigeria. (2010) (7)
- Modification of BRCA 1-Associated Breast and Ovarian Cancer Risk by BRCA 1-Interacting Genes (2011) (7)
- Computer-aided diagnosis: analysis of mammographic parenchymal patterns and classification of masses on digitized mammograms (1998) (7)
- Implementing oncology clinical trials in Nigeria: a model for capacity building (2020) (7)
- Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution. (2013) (7)
- The who, what, when, where, whom, and how of hospitalist care (2002) (7)
- Molecular-Cytogenetic Analysis of HER-2 / neu Gene in BRCA 1-associated Breast Cancers 1 (2002) (7)
- Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes (2020) (7)
- Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women (2012) (7)
- Genetic Variation in IGF 2 and HTRA 1 and Breast Cancer Risk among BRCA 1 and BRCA 2 Carriers (2011) (6)
- Gene-expression profiles in hereditary breast cancer. (2001) (6)
- Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry (2018) (6)
- Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015 (2020) (6)
- Addressing health disparities in cancer with genomics (2021) (6)
- Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities. (2021) (6)
- Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women (2018) (5)
- Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. (2020) (5)
- Genetic Ancestry May Influence the Evolutionary Trajectory of Cancers. (2018) (5)
- Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care (2020) (5)
- Primary structure-based function characterization of BRCT domain replicates in BRCA1. (2006) (5)
- Recurring Chromosome Rearrangements in Human Cancer (2003) (5)
- Chromosome band 16q22‐linked familial AML: Exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms (2004) (5)
- Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. (1994) (5)
- Genetic testing of families with hereditary diseases. (1996) (5)
- A meta‐analysis approach with filtering for identifying gene‐level gene–environment interactions (2018) (5)
- Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC-derived probes. (1995) (5)
- Knowledge of Genetic Counseling Among Patients With Breast Cancer and Their Relatives at a Nigerian Teaching Hospital (2018) (5)
- Knowledge and health beliefs assessment of Sickle cell disease as a prelude to neonatal screening in Ibadan, Nigeria (2019) (5)
- p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability (2020) (5)
- The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. (2014) (5)
- Department of Pathology, Thom as Jeffe rson University, Identific ation of conserved gene expression features between murine mammary carcinoma models and human breast tumors. (2007) (5)
- Computerized Analysis of Digitized Mammograms of Women with Low Breast Cancer Risk and of BRCA1/BRCA2 Gene-Mutation Carriers (1998) (5)
- The BRCA1 Pseudogene Negatively Regulates Antitumor Responses through Inhibition of Innate Immune Defense Mechanisms (2021) (5)
- Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients (2012) (5)
- Genetics of Breast Cancer in Blacks (2001) (4)
- Abstract 2679: Integration of DNA repair deficiency and immune biomarkers to predict which early-stage triple-negative breast cancer patients are likely to respond to platinum-containing regimens vs. immunotherapy: The neoadjuvant I-SPY 2 trial (2019) (4)
- Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain. (2016) (4)
- Author Correction: Assembly of a pan-genome from deep sequencing of 910 humans of African descent (2019) (4)
- USPSTF Recommendations for BRCA1 and BRCA2 Testing in the Context of a Transformative National Cancer Control Plan. (2019) (4)
- Short communication - GLYCEMIC CONTROL AND PAIN THRESHOLD IN ALLOXAN DIABETIC RATS (2004) (4)
- No evidence for core-binding factor CBFβ as a leukemia predisposing factor in chromosome 16q22-linked familial AML (2004) (4)
- The Influence of Spirituality and Religiosity on US Oncologists’ Personal Use of and Clinical Practices Regarding Complementary and Alternative Medicine (2020) (4)
- Breast Cancer Knowledge Assessment of Health Workers in Ibadan, Southwest Nigeria (2020) (4)
- Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report. (2015) (4)
- Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet? (2020) (4)
- Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids (1994) (4)
- A Preliminary Study of the Suitability of Archival Bone Marrow and Peripheral Blood Smears for Diagnosis of CML Using FISH (2014) (4)
- Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center (2021) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- Characterizing the gut microbiome of patients with triple-negative breast cancer. (2019) (4)
- Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry (2017) (4)
- Detection of germline variants in Brazilian breast cancer patients using multigene panel testing (2022) (4)
- A method for screening arrayed cosmid libraries with mega insert yeast artificial chromosomes. (1995) (4)
- Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
- Genome-wide association studies in women of African ancestry identified 3 q 26 . 21 as a novel susceptibility locus for oestrogen receptor negative breast cancer (2017) (3)
- Cancer Susceptibility Genetic Testing in a High-Risk Cohort of Urban Ashkenazi Jewish Individuals (2018) (3)
- Identification of conserved gene expression features across human and murine mammary tumors (2006) (3)
- Longitudinal follow-up after telephone disclosure in the randomized COGENT Study (2020) (3)
- Abstract P3-06-05: Evaluation of anin vitroderived signature of olaparib response (PARPi-7) as a predictive biomarker of response to veliparib/carboplatin plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 TRIAL: (2015) (3)
- Abstract GS4-02: Analysis of clinical outcomes and expression-based immune signatures by race in the I-SPY 2 trial (2022) (3)
- USPSTF Recommendations for BRCA1 and BRCA2 Testing in the Context of a Transformative National Cancer Control Plan. (2019) (3)
- Cancer Control in Africa 3 Treatment of cancer in sub-Saharan Africa (2013) (3)
- c-Met/HGF pathway in breast cancer cells and inhibition with specific small molecule inhibitor, SU11274 (2005) (3)
- Abstract 859: Gene and pathway differences between MammaPrint High1/High2 risk classes: results from the I-SPY 2 TRIAL in breast cancer (2016) (3)
- Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers (2021) (3)
- Early onset breast cancer in black women of african ancestry: Genetic or environmental influence? (2005) (3)
- Ancestrally unbiased polygenic breast cancer (BC) risk assessment. (2021) (3)
- Comparison of Breast CancerMolecular Features and Survival byAfrican and EuropeanAncestry in The Cancer GenomeAtlas (2017) (3)
- Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers (2005) (3)
- Breast tumor morphometry in relation to race reveals significant differences among Nigerians, African-Americans and Caucasian Americans. (2004) (3)
- Drinking water infrastructure in the Ashanti Region of Ghana: developing a model for sustainable interventions by non-governmental organizations (2015) (3)
- Confronting Genetic Testing Disparities (2017) (3)
- N-acetyltransferase 2 enzyme genotype–phenotype discordances in both HIV-negative and HIV-positive Nigerians (2019) (3)
- Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers (2021) (3)
- Lack of association between common UGT2B nonsynonymous single‐nucleotide polymorphisms and breast cancer in populations of African ancestry (2012) (3)
- Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer (2023) (3)
- EVIDENCE FOR SIGNAL TRANSDUCTION THROUGH THE TNF RECEPTOR PATHWAY IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: 139 (1997) (3)
- Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer (2022) (3)
- Author Correction: Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations (2019) (3)
- Abstract S2-06: DNA repair deficiency biomarkers and MammaPrint high1/(ultra)high2 risk as predictors of veliparib/carboplatin response: Results from the neoadjuvant I-SPY 2 trial for high risk breast cancer (2017) (3)
- Parent perceptions of offspring responses to parental communication of BRCA1/2 test results. (2009) (3)
- An update on the management of breast cancer in Africa (2017) (3)
- Abstract P3-07-48: Prediction of complete pathologic response to veliparib/carboplatin plus standard neoadjuvant therapy in HER2 negative breast cancer: Exploratory protein pathway marker results from the I-SPY 2 trial (2016) (3)
- Race and subset analyses in clinical trials: time to get serious about data integration. (2011) (3)
- Validation of Mammographic Texture Analysis for Assessment of Breast Cancer Risk (2010) (3)
- Formal Assessment of Teamwork Among Cancer Health Care Professionals in Three Large Tertiary Centers in Nigeria (2020) (3)
- Report on the 1996 International chromosome 9 workshop (1997) (2)
- A prospective paired survey of oncologist and patient attitudes toward therapeutic cancer clinical trial (CT) enrollment in a diverse academic health center patient population. (2010) (2)
- Social, biological, and tumor characteristics of 139 African American (AA) women with newly diagnosed breast cancer in Chicago. (2010) (2)
- Effect of variable gain on computerized texture analysis on digitalized mammograms (2010) (2)
- Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil (2022) (2)
- Protective effect of longstanding lactation and reproductive factors: a case–control study in North Tanzania (2012) (2)
- Two truncating variants in FANCC and breast cancer risk (2019) (2)
- Abstract OT1-10-02: I-SPY2 endocrine optimization protocol (EOP): A pilot neoadjuvant endocrine therapy study with amcenestrant as monotherapy or in combination with abemacicilib or letrozole in molecularly selected HR+/HER2- clinical stage 2/3 breast cancer (2022) (2)
- Differences in somatic TP53 mutation type in breast tumors by race and receptor status (2021) (2)
- Mammographic Breast Pattern in Postmenopausal Women in Ibadan, South-Western Nigeria (2016) (2)
- Disclosure patterns and decision making preferences in BRCA 1/2 mutation carriers with young adult and minor children. (2006) (2)
- Genetic Markers in Breast Tumors with Hereditary Predisposition (2008) (2)
- Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database (2023) (2)
- Abstract 2590: Development and validation of a breast cancer risk prediction model for black women: findings from the Nigerian breast cancer study: Table 1 (2016) (2)
- Multimodal Prediction of Breast Cancer Recurrence Assays and Risk of Recurrence (2022) (2)
- Should genetic testing for BRCA1/2 be permitted for minors? Opinions of parents who completed BRCA1/2 testing (2008) (2)
- BRCA1 methylation contributes to the triple-negative breast cancer phenotype. (2009) (2)
- GENETIC TESTING OF FAMILIES WITH HEREDITARY DISEASES. AUTHORS' REPLY (1996) (2)
- Cancer Genetics: Risk Assessment and Prevention Strategies (2005) (2)
- Towards an Oncology Database (ONCOD) Using a Warehousing Approach. (2012) (2)
- Preferential Loss of Expression 0f16INK4a Rather Than p1' in Breast Cancer1 (1996) (2)
- Doing better and being better in breast cancer care: an interview with Funmi Olopade (2021) (2)
- Hidden Dangers: A Cryptic Exon Disrupts BRCA2 mRNA (2012) (2)
- Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next generation sequencing. (2013) (2)
- The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge (2022) (2)
- Opportunities in Genetic Epidemiology in Developing Countries (2013) (2)
- Identifying challenges to breast cancer care coordination at urban community-based primary care clinics. (2018) (2)
- Atopy, Helminthic Infection and Serum Immunoglobulins in Adult Asthma in SW Nigeria. (2009) (2)
- Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent. (2020) (2)
- Evaluation of slide storage and detection of molecular markers by immunohistochemistry (IHC) in formalin-fixed, paraffin embedded endometrial cancer tissues from a clinical trial: A GOG study (2014) (2)
- Power spectral analysis of mammographic parenchymal patterns (2006) (2)
- Magnetic resonance angiography reveals increased arterial blood supply and tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer. (2020) (2)
- The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo (2013) (2)
- Breast Cancer and Race (2005) (2)
- Pancreatic cancer and BRCA mutation in familial breast cancer families (2005) (2)
- Generation of small insert genomic FISH probes with high signal intensity suitable for deletion mapping. (1997) (2)
- DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial (2017) (2)
- Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent and/or metastatic squamous cell carcinoma of the head and neck. (2011) (2)
- Personalized Biomedical Data Integration (2011) (2)
- BROCA gene panel testing in African descendants from northeastern Brazil: Genetic susceptibility profile of an admixed population. (2017) (2)
- An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer (2022) (2)
- Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US (2023) (2)
- Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers (2011) (1)
- Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
- Genetic testing for susceptibility to cancer. Task Force on Cancer Genetics Education. (1998) (1)
- Pre- and post-treatment body weight and prognosis in a multiethnic cohort of breast cancer patients. (2018) (1)
- Outcomes after breast cancer in an ethnically diverse cohort of high-risk patients: Differences in survival based on BRCA1/BRCA2 mutation status (2007) (1)
- Abstract P4-05-10: Comparative analysis of genomic landscape reveals heterogeneity in HER2-positive primary breast cancers and residual disease following neoadjuvant therapy (2020) (1)
- Serum Micronutrients in a Rural 13-14 Yr Old Asthma Cohort in Southwest Nigeria. (2009) (1)
- Attitudes of breast cancer patients and oncology staff towards randomized clinical trials in southwest Nigeria. (2018) (1)
- Utilization of Complementary Alternative Medicine, Diet, and Exercise Among Women at High Risk for Developing Breast Cancer (2020) (1)
- Assessing perceptions of genetic risk and breast cancer of women diagnosed and undiagnosed with breast cancer in Ibadan, Nigeria (2016) (1)
- BRCA1 promoter methylation in breast cancer cell lines and primary tumors (2007) (1)
- Care Coordination for Breast Cancer Survivors in Urban Underserved Communities: Will Treatment Summaries and Survivorship Care Plans Be Enough? (2020) (1)
- Abstract B11: Replication of previously identified breast cancer susceptibility loci in a breast cancer case-control study on women of African ancestry (2014) (1)
- BRCA 1 / BRCA 2 prediction model (2004) (1)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers (2016) (1)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
- Neoadjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): Efficacy and safety in a phase II feasibility study. (2012) (1)
- Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study (2021) (1)
- Abstract 624: A case control study of benign breast disease and breast cancer among indigenous African women (2019) (1)
- 15 - Fluorescence in situ Hybridization of BRCA1Gene in Breast Carcinoma (2002) (1)
- Relationship between BRCA1 promoter methylation and sensitivity of breast cancer cell lines to cisplatin and paclitaxel (2007) (1)
- Health-related quality of life among high-risk women in an MRI surveillance study (2007) (1)
- Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal. (2022) (1)
- Fluvastatin has biologic effects on stage 0 and 1 breast cancer. (2009) (1)
- Abstract P3-12-01: Increased Rate of HER2-Positive Breast Cancers among Women with GermlineTP53Mutations (2010) (1)
- Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers (2022) (1)
- Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome. (2013) (1)
- Abstract 462: Cytotoxic CD8+ T cells and immunosuppressive T regulatory cells are associated with aggressive breast cancer subtypes (2015) (1)
- Abstract 858: Combining sensitivity markers to identify triple-negative breast cancer patients most responsive to veliparib/carboplatin: results from the I-SPY 2 TRIAL (2016) (1)
- Is recent decline in breast cancer incidence equal across different US racial groups (2008) (1)
- Abstract SS1-06: Racial disparities in pathological complete response among breast cancer patients receiving neoadjuvant chemotherapy (2021) (1)
- The Genetics of Triple-Negative Breast Cancer (2018) (1)
- A retrospective analysis of the relationship between diabetes, metformin use, and survival in advanced endometrial cancer patients treated with chemotherapy. (2014) (1)
- Abstract LB-425: Replication of 18 susceptibility loci of breast cancer in women of African ancestry (2011) (1)
- Janet Davison Rowley 1925–2013 (2014) (1)
- Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (2019) (1)
- Breast tumor morphometry in relation to race reveals significant differences among Nigerians, African-Americans and Caucasian Americans (2004) (1)
- Characterization of aggressive breast cancer in African American and Caucasian women: Patterns of gene expression in primary breast tumors (2004) (1)
- Formal assessment of teamwork among cancer health care professionals in 3 large tertiary centers in Nigeria. (2017) (1)
- Survivorship patterns of histopathological variants and molecular subtypes of breast cancer in a teaching hospital in Nigeria (2016) (1)
- Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study (2018) (1)
- Comprar Principles of Molecular Oncology | Bronchud, Miguel H. | 9781934115251 | Springer (2008) (1)
- Association of Proliferating Macrophages with High Grade, Hormone Receptor Negative Breast Cancer. (2009) (1)
- Causes and remedies for low research productivity among postgraduate scholars and early career researchers on non-communicable diseases in Nigeria (2019) (1)
- Consensus molecular subtyping of colorectal cancer by immunohistochemistry, an imperative for a resource limited setting: Report of a Nigerian study (2021) (1)
- Breast cancer surveillance in high-risk women with magnetic resonance imaging every 6 months. (2013) (1)
- Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk (2018) (1)
- Obituary: Janet Davison Rowley 1925-2013. (2014) (1)
- Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition (2022) (1)
- The influence of spirituality and religiosity on the personal use and practice patterns with complementary and alternative medicine (CAM): A national survey of US oncologists. (2016) (1)
- Abstract 1582: Identification of miRNAs that regulate breast cancer stem cells and spontaneous metastases in orthotopic mouse models (2011) (1)
- Abstract B07: Molecular characterization of colorectal cancer in West Africans (2017) (1)
- Acute Myeloid Leukemia and Myelodysplastic Syndrome Associated with Prior Cytotoxic Therapy (2003) (1)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (1)
- Germline ATM mutations in families with early-onset and familial gastroesophageal and colorectal cancers. (2017) (1)
- Abstract PD8-05: Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry (2017) (1)
- Survey of medical student knowledge in oncology and survivorship care in Nigeria: A pilot study. (2019) (1)
- Germline mutational analysis of the C19orf62 gene in African-American women with breast cancer (2011) (1)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
- Abstract 994: Long noncoding RNAs generated from the BRCA1 pseudogene regulate genomic instability and homologous recombination repair (2016) (1)
- Characterization of aggressive breast cancer in African American and Caucasian women: Patterns of gene expression in primary breast tumors. (2004) (1)
- Computerized analysis of mammographic parenchymal patterns using fractal analysis (2003) (1)
- Prophylactic oophorectomy in BRCA1/2 carriers (2004) (1)
- Telephone disclosure of BRCA1/2 test results? Experience and opinions of genetic counselors and consumers. (2016) (1)
- Prevalence and Spectrum of Breast Cancer Inherited Mutations in Uganda and Cameroon Women (2018) (1)
- Identification of Novel Common Breast Cancer Risk Variants in Latinas at the 6q25 Locus (2018) (1)
- CDKN2 Deletions in Leukemia-Derived Cell Lines: Detection by Fluorescence In Situ Hybridization with Interphase Cells (1997) (1)
- Abstract 2386: Molecular-cytogenetic analysis of the maternal embryonic leucine-zipper kinase (MELK) oncogene in cancer (2014) (1)
- Abstract IA25: Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care (2020) (0)
- Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda. (2021) (0)
- Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening-Reply. (2018) (0)
- Abstract P1-05-11: Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in the cancer genome atlas (2017) (0)
- Clinical Research in International Settings: Opportunities, Challenges, and Recommendations (2018) (0)
- Abstract OT-21-01: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM) (2021) (0)
- Abstract OT3-03-02: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM) (2020) (0)
- Profile of Women With Breast Disorders in Pregnancy and Lactation and Additional Investigation Uptake (2018) (0)
- Real-world evidence on predictors of survival for hormone-positive and triple-negative advanced breast cancer by treatment and BRCA status in the United States. (2022) (0)
- Abstract 3734: Alcohol consumption and breast cancer risk among Nigerian women (2011) (0)
- Abstract 1312: Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry in the ROOT Consortium (2017) (0)
- Abstract 2950: Biomarkers of immune infiltration for multiplex immunofluorescence in breast cancer (2017) (0)
- Extended follow-up in the COGENT study: A randomized study of in-person versus telephone disclosure of cancer genetic test results. (2017) (0)
- Adapting a Medical School Cancer Research Education Program to the Virtual Environment: a Mixed-Methods Study. (2022) (0)
- Advances in Brief Increased pl 6 Levels Correlate with pRb Alterations in Human Urothelial Cells 1 (2006) (0)
- Gender differential in inclination to donate brain for research among Nigerians: the IBADAN Brain Bank Project (2019) (0)
- Abstract LB-124: RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma (2011) (0)
- Compliance to adjuvant hormone therapy for black and white women with breast cancer. (2011) (0)
- Abstract P2-11-21: Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model (2022) (0)
- Abstract P1-06-05: Clinical practice and mortality in patients with oncotype DX intermediate score: What do we know about the gray zone? (2018) (0)
- Familial Cancer Syndromes in Africa (2012) (0)
- The Effect of Alpha Thalassemia, HbF and HbC on Haematological Parameters of Sickle Cell Disease Patients in Ibadan, Nigeria (2022) (0)
- Assessment of humoral immunity and nutritionally essential trace elements in steady-state sickle cell disease Nigerian children before and after Prevenar 13 pneumococcal vaccination (2022) (0)
- Self-Efficacy and Willingness to Implement Narrative Communication Interventions: Mixed Methods Study Among Breast Cancer Patients and Survivors at the University College Hospital, Ibadan, Nigeria (2022) (0)
- An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study (2022) (0)
- Financial and Psychosocial Distresses of Breast and Cervical Cancer Patients at the University College Hospital, Ibadan (2022) (0)
- REPORT ON THE 3RD INTERNATIONAL WORKSHOP ON CHROMOSOME-9 AND ON TUBEROUS SCLEROSIS HELD AT QUEENS COLLEGE, CAMBRIDGE, UK, 9-11 APRIL AND 12 APRIL 1994 (1994) (0)
- BRCA1 and BRCA2 in Underserved and Special Populations (2007) (0)
- Abstract B20: Genetic testing for inherited colorectal cancer among African Americans and Caucasians in the era of multigene panels (2016) (0)
- Abstract A51: Understanding community-based primary care providers' attitudes toward caring for breast cancer survivors. (2012) (0)
- DNA repair the 70-gene ultra-high risk as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial. (2017) (0)
- A chromosome 16 locus for familial leukemia. (1997) (0)
- Abstract 215: Developing an integrated prognostic score using germline risk variants and RNA expression from primary breast cancers for prognostication of survival across subtypes (2021) (0)
- Proteomic profile of African American breast cancer (2007) (0)
- JANET DAVISON ROWLEY. (2015) (0)
- Su1079 Lynch Syndrome in African Americans (2013) (0)
- BRCA1 Y101X, a recurrent mutation with potential founder effect in Nigerian breast cancer patients (2006) (0)
- Prophylactic oophorectomy in BRCA1/2 carriers. (2004) (0)
- Lightweight Mobile Automated Assistant-to-physician for Global Lower-resource Areas (2021) (0)
- Abstract PS18-12: Comparative analysis of differential gene expression by ancestry using primary breast cancers from Nigeria and the cancer genome atlas (TCGA) (2021) (0)
- Abstract 2731: Cell-type deconvolution of African American breast tumors reveals spatial heterogeneity of the immune microenvironment (2021) (0)
- Towards to an Oncology Database (ONCOD) using a data warehousing approach (2012) (0)
- Association of downregulation of toll-like receptor 3 (TLR3) expression with aggressive breast cancer (BC). (2013) (0)
- Should Minors Be Offered BRCA1/2 Testing for Hereditary Breast Cancer? Opinions of Parents Who Have Undergone BRCA1/2 Testing. (2009) (0)
- Influence of a Teaching Session on Breast Self-Examination and Adherence Among Pregnant and Lactating Women in Ibadan, Nigeria (2019) (0)
- Validation of the RSClin risk calculator using the National Cancer Database (NCDB). (2021) (0)
- Mutations in context: implications of BRCA testing in diverse populations (2017) (0)
- Breast Cancer and Race: A Rising Tide Does Not Lift All Boats Equally (2005) (0)
- Using A Behavioral Model to Assess The Barriers And Facilitators to Engaging Local Healthcare Providers In Conducting Interventional Cancer Trials In Nigeria (2020) (0)
- Patient-reported outcomes in a multicenter randomized study of in-person versus telephone disclosure of genetic test results for cancer susceptibility. (2016) (0)
- Abstract 2633: Radiogenomics of breast cancer using DCE-MRI and gene expression profiling (2016) (0)
- Abstract C01: Assessment of interest for breast cancer prevention trial participation among BRCA mutation carriers (2013) (0)
- Microcompetition with Foreign DNA and the Origin of Chronic Disease (reivew) (2005) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Genetic Testing for Cancer Risk Assessment in Patients With Breast and Ovarian Cancer in Ibadan, Nigeria (2019) (0)
- Can We Leverage HIV Prevention Programs for Breast Cancer Interventions? Preliminary Findings From a Study in Nigerian Women Working in the Informal Work Sector (2020) (0)
- Abstract IA19: Homologous recombination repair deficiency and breast cancer progression in high-risk populations (2018) (0)
- Association of breast cancer risk in women of African ancestry with genetic variants in the TET-related DNA demethylation pathway. (2017) (0)
- Title: the Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer Statement of Translational Relevance (2015) (0)
- Abstract 5066: Molecular profiles of breast cancer in Barbados (2011) (0)
- A functionally significant SNP in TP53 and breast cancer risk in African-American women (2017) (0)
- Case-control study of height, weight and BMI and breast cancer risk in Nigerian women (2008) (0)
- Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India (2022) (0)
- Abstract 1363: Associations between fatalistic beliefs, modesty concerns and breast cancer screening in the American Muslim community. (2013) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- A family-based approach to primary prevention of breast cancer. (2009) (0)
- Gefitinib sensitivity in head and neck cancer cell lines is mediated by effects of the agent on downstream AKT and STAT3 activation (2006) (0)
- Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? . (2004) (0)
- Abstract SS1-04: Comprehensive genomic and transcriptomic profiling of molecular subtypes reveal ancestral differences in the activity of signaling pathways between patients with African and European ancestry (2021) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Abstract B69: Macrophages along with pathogens in the microenvironment enhance the aggressive behavior of triple-negative breast cancer (TNBC) in an in vitro model. (2012) (0)
- Protein tyrosine kinase 6 (PTK6, BRK) amplification in HER2+breast cancer as a mechanism of HER2 resistance (2013) (0)
- Clinical evaluation of germline polymorphisms (SNPs) associated with capecitabine (C) toxicity (tox) in metastatic breast cancer (MBC). (2015) (0)
- The role of VEGFR-2 genetic variation in breast cancer progression. (2009) (0)
- Abstract HER2-11: HER2-11 Epidemiology and Prognosis of HER2-Low Breast Cancer (BC) in the National Cancer Data Base (NCDB) (2023) (0)
- Abstract 3278: The effect of cold ischemia time on protein expression in breast cancer tissues (2014) (0)
- Breakpoint Junctions ofChromosome 9pDeletions in TwoHumanGlioma CellLines (1994) (0)
- The risks of cancer in older women with BRCA pathogenic variants: How far have we come? (2022) (0)
- Genome-wide association study of asthma in individuals of African ancestry reveals novel asthma susceptibility loci (2017) (0)
- Abstract B53: Analysis of Wnt signaling as a determinant of racial disparities in colorectal cancer outcomes. (2012) (0)
- Abstract 943: A comprehensive examination of breast cancer risk loci in African American women (2014) (0)
- A phase I trial of the IGF-1R antibody IMC-A12 in combination with temsirolimus in patients with metastatic breast cancer. (2012) (0)
- Abstract 3552: Selective inhibition of copper metabolism as a novel approach to treat triple-negative breast cancer (2017) (0)
- Ancestry-based differences in hereditary cancer genetic testing. (2017) (0)
- Racial differences in a high-risk colorectal cancer referral population: a single-center experience (2011) (0)
- Abstract B41: Molecular linkages between metabolic imbalance, genome stability, and triple-negative breast cancer (2011) (0)
- Abstract 5047: Self-supervised deep learning to assess breast cancer risk (2022) (0)
- Abstract LB-149: A novel strategy to inhibit CpG island hypermethylation and restore BRCA1 expression (2015) (0)
- Shared heritability and functional enrichment across six solid cancers (2019) (0)
- 1145 Nine New Alternatively Spliced Isoforms of BRCA2 MRNA –a Clue for Genetic Variants Classification (2012) (0)
- Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach (2021) (0)
- Human Breast Cancer Susceptibility to Paclitaxel Therapy Is Independent of Bcl-2 Expression 1 (2000) (0)
- Abstract B059: Can health system engagement facilitate greater utilization of genetic tests to predict cancer risk? A health disparities exploration of national survey data (2020) (0)
- Lifestyle modifications including complementary and alternative medicine and quality of life among women at high risk for breast cancer. (2009) (0)
- Abstract P3-14-15: The impact of race and age on response to neoadjuvant therapy and long-term outcomes in black and white women with early-stage breast cancer (2022) (0)
- Abstract 5092: Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma (2011) (0)
- Abstract 28: Integrating genomic and transcriptomic data to identify genetic loci associated with breast cancer risk in women of African ancestry (2020) (0)
- Abstract C52: Associations between religion-related factors and breast cancer screening among American Muslims (2014) (0)
- Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p2l (chromosomal (2005) (0)
- Abstract P6-01-06: Identification of Molecular Subtypes of DCIS and Invasive Breast Cancer Using Computerized Image Analysis for Data Integration (2010) (0)
- Recall rate in a semi-annual breast surveillance program for high-risk women. (2013) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) (0)
- Validation of breast cancer biomarkers between a field immunohistochemistry laboratory in Nigeria and its US-based counterpart. (2009) (0)
- Impact of Post-diagnosis Weight Change on Survival Outcomes in a Multiethnic Cohort of Breast Cancer Patients (2020) (0)
- Evaluating psychosocial and belief differences in a diverse racial and socioeconomic cancer population. (2010) (0)
- Abstract 3004: Specific microRNAs associate with aggressive breast tumor phenotypes in an ethnically diverse patient cohort (2010) (0)
- Janet Davison Rowley: 5 April 1925 * 17 December 2013 (2015) (0)
- Breast Cancer Research to Support Evidence-Based Medicine in Nigeria: A Review of the Literature (2021) (0)
- Title. BRCA1 and BRCA2 Mutations in an Ethnically Diverse Cohort of High-Risk Women: A Comparison Between African-American and Caucasian Families (2004) (0)
- P063: Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 individuals* (2023) (0)
- Breast Cancer and the Environment: A Pilot Study of Nigerian Women (2019) (0)
- Longitudinal follow-up after telephone disclosure in the randomized COGENT study (2020) (0)
- Reply to Q. Chu et al (2021) (0)
- Abstract 4040: PD-L1 expression level and CD8+/FoxP3+T cell ratio in breast cancer and prognosis (2019) (0)
- Abstract 4199: Regulation of microRNA-29c expression in different subtypes of breast cancer. (2013) (0)
- Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations (2019) (0)
- Assembly of a pan-genome from deep sequencing of 910 humans of African descent (2018) (0)
- Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients (2021) (0)
- Study on Mammographic Breast Pattern in Postmenopausal Women in Ibadan, South-Western Nigeria (2021) (0)
- Abstract P5-19-01: The impact of streamlined processes and patient-directed messaging to improve enrollment in a remote, pragmatic clinical trial (2022) (0)
- DNA repair deficiency biomarkers and identification of ER-positive breast cancer patients who may benefit from veliparib/carboplatin: Results from the I-SPY 2 trial. (2017) (0)
- Abstract LB-003: Racial differences of intron retention and DNA methylation in breast cancer (2017) (0)
- Modulation of the Wnt/β-catenin pathway is associated with the basal-like breast cancer phenotype. (2009) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Subject Index, Vol. 76, 1997 (1997) (0)
- Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity (2013) (0)
- Genetic counseling for pancreatic cancer in a high-risk clinic setting. (2004) (0)
- Abstract 766: Genomic and transcriptomic comparison between breast cancers from patients of African and European genetically determined ancestries demonstrates potential for ancestry specific biomarker-informed therapies (2022) (0)
- University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio, (2014) (0)
- Clinical evaluation of germline polymorphisms (SNPs) associated with disease response to capecitabine in metastatic breast cancer (MBC) (TBCRC 015). (2018) (0)
- Determining clinical relevance of genomic heterogeneity in an ethnically diverse cohort of newly diagnosed patients with breast cancer. (2019) (0)
- Abstract 07: Challenges of applying tumor genome analysis to the germline: Examples from GI oncology (2014) (0)
- Colorectal cancer molecular subtypes by immunohistochemistry in a patient cohort from Nigeria. (2019) (0)
- Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features (2018) (0)
- HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways (2018) (0)
- Genetic Testing and Clinical Management Practices for Variants inNon-BRCA1/2 Breast (and Breast/Ovarian)Cancer Susceptibility Genes: An International Survey by the Evidence-BasedNetwork for the Interpretation of Germline Mutant Alleles (ENIGMA) ClinicalWorking Group (2019) (0)
- How And Why Recurring Chromosomal Abnormalities Occur (2003) (0)
- Preferential Loss of Expression 0 f 16 INK 4 a Rather Than p 1 ’ in Breast Cancer 1 (2005) (0)
- LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications (2018) (0)
- Protein expression of EZH2 significantly increased in colorectal cancer compared with adjacent normal epithelium: A manual and quantitative image analyses (2007) (0)
- Abstract 2620: Contribution of risk variant in miR-125b binding site of BMPR1B in women of African ancestry with breast cancer (2012) (0)
- Abstract P5-03-13: Circular RNAs express heterogeneously across different breast cancer subtypes and correlate with invasive disease-free survival (2023) (0)
- Genetic mechanisms and heterogeneity in familial myeloid leukemia (2007) (0)
- Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response (2022) (0)
- Abstract 4428: Characterizing the tumor-infiltrating T-cell repertoire of breast cancer in indigenous African patients from Southwest Nigeria (2020) (0)
- Dissection of cooperating genetic pathways involved in aggressive early onset breast cancer reveals mutually distinct roles for BRCA1 and HER2/neu genes (2001) (0)
- Breast cancer among African American and sub-Saharan African women: a tale of global inequities (2022) (0)
- Early Breast Cancer (2003) (0)
- Genetic anticipation in BRCA1/2 families after controlling for ascertainment bias and cohort effect. (2014) (0)
- Clinical trials: A key tool in improving breast cancer survival in Nigeria. (2017) (0)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
- Developing novel approaches to breast cancer: Are we there yet? (2007) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- Abstract OT3-15-03: The ARETTA Trial Experience: Radiotherapy Quality Assurance in an International Breast Cancer Trial (2023) (0)
- A breast cancer (BC) risk model incorporating Tyrer-Cuzick version 8 (TCv8) and a polygenic risk score (PRS) for diverse ancestries. (2022) (0)
- Abstract 28: Molecular analysis of colorectal cancer progression in an ethnically diverse cohort reveals a higher prevalence of KRAS mutations in African Americans (2010) (0)
- A metabolome-wide case-control study of african american breast cancer patients (2023) (0)
- Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study (2012) (0)
- Author Correction: Assembly of a pan-genome from deep sequencing of 910 humans of African descent (2019) (0)
- At the Crossroads: The Intersection of the Internet and Clinical Oncology (1999) (0)
- Male breast cancer in BRCA1 and BRCA2 mutation carriers (2018) (0)
- Association of breast cancer risk in BRCA 1 and BRCA 2 mutation carriers with genetic variants showing differential allelic expression (2016) (0)
- Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features (2019) (0)
- Racial and Ethnic Disparities in Breast Cancer : A Multilevel Perspective 753 (2005) (0)
- Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas (2019) (0)
- Interest in and outcomes with web-based education for return of genetic research results for inherited susceptibility to breast cancer. (2018) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- Abstract P5-19-04: The WISDOM study: Reducing sequential steps and implementing parallel workflows in pragmatic trials (2022) (0)
- Abstract P5-19-04: Psychosocial impact of a multi-modality surveillance program for women at high-risk for breast cancer (2018) (0)
- Abstract LB-300: The life history of breast cancer in Nigerian women: Evidence for ethnic differences in tumor evolution based on whole-genome sequencing (2019) (0)
- Racial/ethnic differences in telemedicine utilization and satisfaction among patients with breast cancer during the COVID-19 pandemic. (2022) (0)
- Cancer Epidemiology in the 21 st Century Transforming Epidemiology for 21 st Century Medicine and Public Health (2013) (0)
- Introducing first year medical students to oncology care through an elective seminar series. (2016) (0)
- Introducing medical students to survivorship care through an elective oncology summer program. (2017) (0)
- Abstract 3132: Beta-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. (2013) (0)
- Abstract P4-08-12: Comparative analyses of the prognostic value of oncotype and mammaprint using the National Cancer Database (2019) (0)
- Abstract 3306: Aberrant expression of ribosomal protein p1 and its pseudogene in breast tumors (2014) (0)
- Abstract A027: Endothelial-like properties of triple-negative claudin-low breast cancer cells promote tumor-vascular interactions and tumor permeability (2013) (0)
- Abstract 4807: BACH1 proline hydroxylation regulates the hypoxia response and metastasis in triple negative breast cancer (2023) (0)
- Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing. (2023) (0)
- American Society of Breast Disease Policy Statement on The Use of Breast Magnetic Resonance Imaging (2008) (0)
- Abstract OT-22-01: Opportunities and lessons learned in using electronic health record patient portal (MyChart) for recruitment to the population-based WISDOM study (2021) (0)
- Abstract PD14-05: PD14-05 Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 women (2023) (0)
- Infrastructural Challenges to Radiation Therapy in a Nigerian Teaching Hospital (2018) (0)
- Abstract 1859: Breast cancer risk:tp53 genotyping in a Nigerian population (2010) (0)
- Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis (2013) (0)
- Abstract 5604: Microsatellites in the estrogen (ESR1, ESR2) and androgen receptor (AR) genes and risk of breast cancer in women of African ancestry (2011) (0)
- Racial differences in interest and use of integrative medicine among patients with breast cancer. (2022) (0)
- Approach to cancer management in a tertiary centre: the example of breast cancer (2005) (0)
- Abstract P3-07-05: Not presented (2019) (0)
- Implementation of a Novel Medical School Multidisciplinary and Interprofessional Oncology Curriculum: a Mixed Method Study (2017) (0)
- Abstract 1112: Splicing regulation and BRCA1/2-associated breast cancer risk (2010) (0)
- Abstract 3995: Breast cancer molecular subtypes are reflected in circulating microRNA profiles (2015) (0)
- Abstract 200: A transcribed BRCA1 pseudogene regulates gene expression and promotes breast cancer cell proliferation. (2012) (0)
- Innovative Strategies for Developing Biomarker-Informed Cancer Clinical Trials to Accelerate Progress in Precision Oncology in Sub-Saharan Africa. (2022) (0)
- ASO Visual Abstract: Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center (2021) (0)
- Abstract P3-07-08: Molecular subtype-specific expression of long noncoding RNA regulates proliferation of basal-like breast cancer cells (2017) (0)
- Genetic Risks for Breast Cancer in African American Women: Analysis of Candidate Single Nucleotide Polymorphisms from Association Studies. (2009) (0)
- An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
- Abstract P4-02-01: Recall rates during breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study (2018) (0)
- A response to “Personalised medicine and population health: breast and ovarian cancer” (2019) (0)
- Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry (2020) (0)
- Abstract P5-09-02: Breast cancer risk prediction using a polygenic risk score in women of African ancestry: Findings from GWAS in breast cancer in the African diaspora (2017) (0)
- Abstract PL03-03: Inherited susceptibility to cancer: From family reunions to the front line of precision healthcare (2021) (0)
- The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions (2023) (0)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
- Abstract P3-06-13: Transient increase in breast cancer risk after a full term pregnancy among African women (2013) (0)
- Shifting the Paradigm: Reimagining Approaches to Diversifying the Leadership of the Nation's Cancer Centers. (2022) (0)
- Concordance in Hormone Receptor Status between First and Second Breast Cancers. (2009) (0)
- Discordance in estrogen receptor status between primary, metastatic, and second primary breast cancers: Impact of misclassification. (2011) (0)
- Emerging Roles of Pseudogene RNAs in Antitumor and Antiviral Immunity (2021) (0)
- Abstract 3559A: Molecular subtype-specific methylation of the miR-29c promoter in breast cancer correlates with basal-like pattern of gene expression (2014) (0)
- Abstract PD7-06: Unstable mutational profile and heterogeneity of residual breast tumor following neoadjuvant therapy from comprehensive genomic and transcriptomic sequencing (2021) (0)
- Abstract 287: Germline variants and somatic mutation signatures in breast cancer across populations of African and European ancestry (2018) (0)
- Department of Pathology, Thomas Jefferson University, Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors (2020) (0)
- Abstract 717: Diagnosis of basal like breast cancer using DNA methylation markers at the promoters of long noncoding RNAs (2017) (0)
- Abstract 4494: Whole genome sequencing reveals different patterns of mutational mechanisms in breast tumors between women of African and European descent (2016) (0)
- Introducing Medical Students to Radiation Oncology Through an Elective Oncology Summer Program (2016) (0)
- Predictors of BRCA-positive parents' disclosure of cancer risk and risk reduction options to offspring. (2010) (0)
- Abstract 674: A pilot study of physical activity and breast cancer risk in Africa (2012) (0)
- Abstract 2606: Absence of association between common genetic polymorphisms in the TERT-CLPTM1L locus and breast cancer risk in women of African descent (2012) (0)
- Molecular Markers in Hereditary Breast Cancer (2001) (0)
- Abstract 2565: Functional characterization of genetic variants at 16q12 associated with breast cancer in women of African ancestry. (2013) (0)
- Oncology Training Needs Assessment Among Health Care Professionals in Nigeria (2022) (0)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (0)
- Issues and Challenges for Clinical Research in International Settings (2012) (0)
- Abstract P6-05-19: Racial Disparities in the Quality of Life and Vaccination of Breast Cancer Survivors during COVID-19: A Longitudinal Study (2023) (0)
- Evaluating markers of microsatellite instability in an ethnically diverse patient cohort (2007) (0)
- Abstract 4198: Transcriptional regulation of breast cancer microRNAs by GATA3 and TFAP2A (2012) (0)
- Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence (2023) (0)
- National survey of U.S. oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by cancer patients. (2010) (0)
- Using genetic analysis to individualize preventive measures for breast and ovarian cancers (2006) (0)
- Associations between age of menarche and genetic variation in women of African descent: genome-wide association study and polygenic score analysis (2021) (0)
- Abstract 1061: EZH2 expression in different subtypes of human breast cancer (2012) (0)
- Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
- Abstract 1933: Independent evaluation and validation of mammography-based breast cancer risk models in a diverse patient cohort (2022) (0)
- Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response (2022) (0)
- Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival (2023) (0)
- Abstract 2320: Evaluating a polygenic risk score for breast cancer in women of African ancestry (2020) (0)
- Knowledge outcomes in a randomized trial of telephone vs. in-person disclosure of genetic testing: The COGENT study. (2017) (0)
- University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch, (2013) (0)
- Abstract 3331: MicroRNAs regulate breast cancer stem cells and spontaneous metastases in orthotopic xenograft models (2012) (0)
- Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 (2016) (0)
- Diverse indications for risk-reducing salpingo-oophorectomy: Experience from a tertiary care center (2018) (0)
- Abstract P3-06-25: MammaPrint High1/High2 risk class as a biomarker of response to veliparib/carboplatin plus standard neoadjuvant therapy for breast cancer in the I-SPY 2 TRIAL (2015) (0)
- Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status (2021) (0)
- Estrogen Deprivation Therapy and Colon Cancer Risk in Breast Cancer Patients (2010) (0)
- Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data (2016) (0)
- Factors associated with breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, South-western Nigeria (2022) (0)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
- Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry (2016) (0)
- Abstract B123: Using eHealth and data science to dissect breast cancer heterogeneity in the Chicago Multi-Ethnic (ChiMEC) Breast Cancer Cohort (2020) (0)
- Abstract 2029: Wild type BRCA2 mRNA splice variants in normal and breast tumor cells (2011) (0)
- A genome-wide association study of breast cancer in women of African ancestry (2012) (0)
- BRCA1 and BRCA2 mutation carrier predictions using the BRCAPRO model in clinic-based minority families enrolled in the Breast Cancer Family Registry (B-CFR) (2007) (0)
- Genomic profiling of residual tumor after neoadjuvant chemotherapy for breast cancer. (2019) (0)
- Abstract 1373: Circular RNAs generated from theBRCA1pseudogene regulates the DNA damage response through SERBP1 RNA-binding protein (2018) (0)
- The value of TOP2A as a target for anthracycline-based chemotherapy in advanced endometrial carcinoma (EC): NRG Oncology/Gynecology Oncology Group study. (2015) (0)
- Abstract 832: MicroRNA-30c inhibits human breast tumor chemo-resistance by regulating twinfinlin-1 (TWF1) and IL-11. (2013) (0)
- Parental disclosure of genetic test results to young adults, adolescents and children (2005) (0)
- Abstract P2-10-05: A breast cancer multi-racial/ethnic polygenic risk score for improved personalized breast cancer screening (2020) (0)
- Title Identification of novel common breast cancer risk variants at the 6 q 25 locusamong Latinas Permalink (2019) (0)
- The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo (2013) (0)
- Abstract 5468: Gene fusions in breast cancer in Nigerian women (2020) (0)
- Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness. (2011) (0)
- Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy–driven Metabolic Reprogramming (2023) (0)
- Abstract OT2-21-01: Assessing Response to neoadjuvant Taxotere and TrAstuzumab in Nigerian women with HER2-positive breast cancer (ARETTA) (2023) (0)
- Abstract 1176: αB-Crystallin expression across different stages and subtypes of breast cancer analyzed using tissue microarrays (2010) (0)
- Abstract B33: Transcriptional control of genome surveillance and repair by a metabolic switch (2011) (0)
- Feasibility of genetic testing for cancer risk assessment programme in Nigeria (2021) (0)
- Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP) (2023) (0)
- Abstract P5-01-04: Activation of toll-like receptor 7 (TLR7) confers protection in human breast cancer (2013) (0)
- Abstract 1439: Clinical significance of KISS1 protein expression in breast cancer metastasis to brain (2011) (0)
- Abstract 5332: MicroRNA profile of triple-negative breast cancer and prognosis. (2013) (0)
- Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. (2016) (0)
- Abstract P6-03-17: Genomic landscape of breast cancers from women of African ancestry across the diaspora (2016) (0)
This paper list is powered by the following services:
Other Resources About Olufunmilayo Olopade
What Schools Are Affiliated With Olufunmilayo Olopade?
Olufunmilayo Olopade is affiliated with the following schools:
